Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of type V phosphodiesterase inhibitors in the treatment of exercise induced pulmonary hemorrhage in the equine

Use of type V phosphodiesterase inhibitors in the treatment of exercise induced pulmonary hemorrhage in the equine

US Patent 8217049 · Granted Jul 10, 2012

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant2021
Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant2013
System and method for providing visual and audio alerts and cargo capacity on a 2012
Device for administration of nitric oxide to horses spontaneously breathing2005
Use of nitric oxide in the treatment of exercised induced pulmonary hemorrhaging1998